PUBLISHER: BIS Research | PRODUCT CODE: 1668770
PUBLISHER: BIS Research | PRODUCT CODE: 1668770
Asia-Pacific Whole Genome and Exome Sequencing Market: Focus on End User and Country - Analysis and Forecast, 2024-2033
Introduction to Asia-Pacific Whole Genome and Exome Sequencing Market
The Asia-Pacific whole genome and exome sequencing market is projected to reach $1,784.8 million by 2033 from $425.9 million in 2024, growing at a CAGR of 15.13% during the forecast period 2024-2033. WGS analyses the entire genome, whereas WES concentrates on protein-coding regions that contain the majority of disease-related variants. As costs come down and applications increase, these technologies are becoming more and more popular.
Market Introduction
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2024 - 2033 |
| 2024 Evaluation | $425.9 Million |
| 2033 Forecast | $1,784.8 Million |
| CAGR | 17.26% |
The market for whole genome and exome sequencing in Asia-Pacific (APAC) is expanding quickly due to advances in genomics, an increase in the prevalence of genetic disorders, and growing investments in precision medicine. Clinical diagnostics, customised treatments, and biomedical research all depend on whole genome sequencing (WGS), which offers a thorough examination of a person's DNA, and whole exome sequencing (WES), which concentrates on protein-coding regions.
With robust government initiatives, growing biotechnology sectors, and growing partnerships between healthcare providers and research institutions, nations like China, Japan, South Korea, and India are leading this market. The market is expanding due to the declining cost of sequencing technologies, as well as the use of big data analytics and artificial intelligence (AI).
Reproductive health, pharmacogenomics, oncology, and rare disease diagnosis are important applications. Demand in the market is also being influenced by the rise of direct-to-consumer (DTC) testing services and increased awareness of genetic testing. But there are still issues like data privacy, complicated regulations, and moral dilemmas.
All things considered, the APAC whole genome and exome sequencing market is expected to grow significantly due to advancements in technology, rising healthcare costs, and the growing demand for accurate, data-driven medical solutions.
Market Segmentation:
Segmentation 1: by End User
- Pharmaceutical and Biotechnology Companies
- Diagnostic Laboratories
- Hospitals and Clinics
- Research and Academic Institutes
- Others
Segmentation 2: by Country
- Japan
- India
- China
- Singapore
- Australia
- Rest-of-Asia-Pacific
How can this report add value to an organization
Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in genome and exome sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.
Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.
Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.
Key Market Players and Competition Synopsis
Profiled companies have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
Some prominent names established in this market are:
- BGI Group
- Novogene Corporation
Table of Contents
Executive Summary
Scope and Definition
1 Industry Outlook
- 1.1 Market Trends
- 1.1.1 Technological Innovations in the Sequencing Technology
- 1.1.2 Numerous Inorganic Growth Activities in the Market
- 1.2 COVID-19 Impact on Market
- 1.3 Regulatory Framework
- 1.3.1 Legal Requirements and Framework in Japan
- 1.4 Supply Chain Analysis
- 1.5 Market Dynamics Overview
- 1.5.1 Market Drivers
- 1.5.1.1 Growing Applications of Whole Genome and Exome Sequencing in Clinical Diagnostics
- 1.5.1.2 Rising Demand for Personalized Medicine Influencing the Demand for Whole Genome and Exome Sequencing
- 1.5.1.3 Lowering Costs and Increasing Accessibility of Genome Sequencing
- 1.5.1.4 Ongoing Whole Genome Sequencing Government Initiatives around the World
- 1.5.2 Market Restraints
- 1.5.2.1 Privacy and Ethical Concerns due to Increased Risk of Security Breaches
- 1.5.3 Market Opportunities
- 1.5.3.1 Increasing Usage of Sequencing Technology in Emerging Markets
- 1.5.1 Market Drivers
2 Region
- 2.1 Regional Summary
- 2.2 Asia-Pacific
- 2.2.1 Regional Overview
- 2.2.2 Driving Factors for Market Growth
- 2.2.3 Factors Challenging the Market
- 2.2.3.1 By End User
- 2.2.4 China
- 2.2.5 India
- 2.2.6 Australia
- 2.2.7 Japan
- 2.2.8 Singapore
- 2.2.9 Rest-of-Asia-Pacific
3 Markets - Competitive Benchmarking & Company Profiles
- 3.1 Key Strategies and Development
- 3.2 Company Profiles
- 3.2.1 BGI Group (Beijing Genomics Institute (BGI))
- 3.2.1.1 Overview
- 3.2.1.2 Top Products
- 3.2.1.3 Top Competitors
- 3.2.1.4 Key Personnel
- 3.2.1.5 Analyst View
- 3.2.2 Novogene Corporation
- 3.2.2.1 Overview
- 3.2.2.2 Top Products/Product Portfolio
- 3.2.2.3 Top Competitors
- 3.2.2.4 Key Personnel
- 3.2.2.5 Analyst View
- 3.2.1 BGI Group (Beijing Genomics Institute (BGI))
4 Research Methodology
- 4.1 Data Sources
- 4.1.1 Primary Data Sources
- 4.1.2 Secondary Data Sources
- 4.1.3 Data Triangulation
- 4.2 Market Estimation and Forecast
List of Figures
- Figure 1: Asia-Pacific Whole Genome and Exome Sequencing Market (by End User), $Million, 2023, 2026, and 2033
- Figure 2: Key Events to Keep Track of within the Whole Genome and Exome Sequencing Market
- Figure 3: Value and Supply Chain Analysis, Whole Genome and Exome Sequencing Market
- Figure 4: Analysis of Market Navigating Factors, 2023-2033
- Figure 5: Key Clinical Applications of Whole Genome and Whole Exome Sequencing
- Figure 6: Number of Research Papers Mentioning Personalized Medicine in PubMed, 2010-2023
- Figure 7: Decreasing Genome Sequencing Costs
- Figure 8: Map of a Few Recent and Ongoing Government-Funded National Genomic-Medicine Initiatives
- Figure 9: Examples of Security Breaches in Whole Genome and Exome Sequencing
- Figure 10: China Whole Genome and Exome Sequencing Market, $Million, 2023-2033
- Figure 11: India Whole Genome and Exome Sequencing Market, $Million, 2023-2033
- Figure 12: Australia Whole Genome and Exome Sequencing Market, $Million, 2023-2033
- Figure 13: Japan Whole Genome and Exome Sequencing Market, $Million, 2023-2033
- Figure 14: Singapore Whole Genome and Exome Sequencing Market, $Million, 2023-2033
- Figure 15: Rest-of-Asia-Pacific Whole Genome and Exome Sequencing Market, $Million, 2023-2033
- Figure 16: Strategic Initiatives, January 2021-April 2024
- Figure 17: Share of Strategic Initiatives, January 2021-April 2024
- Figure 18: Data Triangulation
- Figure 19: Top-Down and Bottom-Up Approach
- Figure 20: Assumptions and Limitations
List of Tables
- Table 1: Market Snapshot
- Table 2: Opportunities across Regions
- Table 3: Recent Technological Innovations
- Table 4: Few Major Inorganic Growth Activities in the Whole Genome and Exome Sequencing Market
- Table 5: Whole Genome and Exome Sequencing Market (by Region), $Million, 2023-2033
- Table 6: Asia-Pacific Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033
